Analyst Initiates Coverage on IDEAYA Biosciences with Buy Rating and 55 Price Target
BTIG analyst Justin Zelin has recently started covering IDEAYA Biosciences (NASDAQ: IDYA) and has given it a Buy rating with ...
© 2024 Stocks Today
Tag: IDYA
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools